Institutional investors purchased a net $26.9 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 57.46% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 3.6 Million shares of Moderna Inc
LYXOR INTERNATIONAL ASSET MANAGE... Bought 294.4 Thousand shares of Moderna Inc
NORDEA INVESTMENT MANAGEMENT AB ... Bought 243.8 Thousand shares of Moderna Inc